Global Markets for Infectious Disease Treatmentsto grow to $96.8 billion by 2017, BCC Research report says
Infectious diseases are major causes of death around the world. Viral,bacterial, parasitic, and fungal diseases have plagued humankind forcenturies, and attempts to control these diseases have met with greatsuccess, as many fatal diseases are now chronic and manageable. The global market for infectious disease diagnostic, vaccine, and treatmentproducts is being driven by emerging markets in the BRIC (i.e., Brazil, Russia,India, and China) countries, with children the most vulnerable group.In spite of numerous technological advancements, microbes havetransformed themselves to outwit current medications. The constantcombining and reinventing of microbes calls for improved antibiotic and viralmedications to sustain the progress made in addressing the most aggressiveof infectious diseases.BCC Research has published a report to provide valuable information on theglobal market for infectious disease treatments. According to BCC‘s report,
,the global market for infectious disease diagnostic, vaccine, andpharmaceutical products was valued at $59.2 billion in 2011 and $66.4billion in 2012. The report expects promising market growth, with overallmarket value to reach $96.8 billion by 2017, after increasing at a compoundannual growth rate (CAGR) of 7.8%. The report provides a detailed analysis of the global infectious diseasemarket, with emphasis on seven major infectious diseases (i.e., humanimmunodeficiency virus/acquired immunodeficiency virus [HIV/AIDS];hepatitis A, B, C; malaria; rotavirus/diarrhea; measles; pneumonia; andtuberculosis [TB]). The report includes a discussion on technologicaldevelopments, future trends, and emerging opportunities. This BCC Research market report organizes information from diverse sourcesinto a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention,emerging pharmaceutical and diagnostic products, and an applicable patentssection. The information presented through this report is organized by typeof infectious disease (i.e., bacterial, viral, parasitic) and appropriatetreatments, both current and anticipated; major players in the marketplace;market conditions; and current and projected revenues.